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Adherence is tremendously important for efficiency and safety of pharmacotherapy 
and has a significant influence on its clinical, economic and humanistic outcomes, which can 
be observed both on the individual level of the patient as well as on the overall healthcare 
system. The inadequate degree of adherence is a long-lasting and widely present problem 
which can have immense and long-term consequences. Therefore, the issue of adherence is 
a big challenge for medical professionals in clinical practice. 
The concept of adherence is based on cooperation between patients and medical 
team members in the process of therapy management. It is focused on patients and implies 
a two-way transfer of information, agreement and shared responsibility for success in reali-
zation of adequate therapy regime and defined goals.   
Although there are numerous methods for adherence assessment, the evaluation of 
this parameter is still considered problematic. The complexity of adherence can be seen in 
its multidimensionality since numerous factors which individually and in mutual interaction 
affect medicine-taking behavior and thus create a framework that determines the achieved 
level of adherence have been identified and analyzed.  
Considering the fact that poor adherence is one of the main preventable causes of 
unsatisfactory therapy results and excessive costs of medical care, it is evidently necessary 
to ensure a high quality base in the form of knowledge, skills and motivation at the 
healthcare system level for adherence evaluation and improvement, as well as a multidisci-
plinary approach based on coordinated activities of healthcare policy creators, researchers 
and medical professionals. Acta Medica Medianae 2016;55(1):51-58. 
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Adherencе is exceptionally important for the 
efficiency and safety of pharmacotherapy, as well 
as for the realization of desired therapeutic out-
comes. Medicines belong to the most often used 
medical technologies and the significance of their 
appropriate use is reflected in clinical, economic 
and humanistic outcomes of the therapy, both at 
the individual level of the patient and the overall 
healthcare system. Inadequate degree of adher-
ence is a long-lasting and widely present problem 
which can have large and long-term consequences. 
This is the reason why the issue of adherence is a 
big challenge for health professionals in clinical 
practice (1,2). Many terms are used in literature 
and in practice in relation with the medication-tak-
ing behavior. Terms such as compliance, adher-
ence, persistence and concordance are frequently 
inappropriately used as synonyms, although they 
imply a different approach in consideration of the 
role of patients in adequate use of medications, as 
well as the relation between patients and members 
of the healthcare team. Nevertheless, even though 
there is a rise of interest in this domain, there are 
still misunderstandings and inconsistencies regard-
ing definitions and terminology of these concepts 
that seem similar but are rather different (3).  
Historical texts indicate that since the time of 
Hippocrates (460–370 BC) there has existed a fear 
that patients do not follow instructions and recom-
mendations of their doctors and do not use pre-
scribed medications while at the same time many 
of them complain that the therapy has been inef-
fectual. At the end of the 19th century and the be-
ginning of the 20th century the terminology used 
by physicians to describe incompliant patients has 
frequently been extremely critical and condemning.  
There has been a particularly strict attitude towards 
people that had contagious diseases such as tuber-
culosis who have not adhered to instructions of 
their doctors. Such patients were described as “vi-
cious consumptives, careless, irresponsible and/or 
recalcitrant” (3,4).  
From these reflections healthcare profession-
als and researchers showed an ever-growing inter-
est in the issue of adherence, considering that 
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awareness has been developed about its signifi-
cance in the overall success of a therapy.  In the 
early 70’s of the 20th century a basis was been cre-
ated for further contemplation and research of com-
pliance, when two symposiums/ workshops were 
organized at McMaster University Medical Centre in 
Hamilton (Canada) in 1974 and 1975 (5). The term 
compliance was introduced in medical practice in 
the year 1975 as an official Medical Subject Heading 
(MeSH) in the US National Library of Medicine (6), 
and a particularly significant advancement in that 
sphere was achieved in the year 1976 when Sackett 
and Haynes published a book called Compliance 
with Therapeutic Regimens (7). In that period the 
interest of professionals was primarily directed to 
potential consequences of unfulfilled compliance in 
the sense of clinical outcomes and results of clinical 
studies, as well as in developing practical methods 
for quantitative evaluation of coherence between a 
prescribed and realized therapeutic regimen (5). In 
that period, the issue was not considered from the 
perspective of the patient (8). A later body of re-
search addressed the issue of patients’ influence on 
the choice and prescription of therapy and their role 
in therapy management in everyday life. The term 
pharmionics was introduced in the year 1987 and 
implies a discipline dealing with research of use, 
misuse and abuse of prescribed medicines in a pop-
ulation of ambulatory patients (9).  
The International Society for Pharmacoeco-
nomics and Outcomes Research - ISPOR Medication 
Compliance and Persistence Work Group defines 
compliance as the extent to which a patient con-
forms for the recommendations made by the pro-
vider with respect to timing, dosage, and frequency 
of medication taking (10). Such a definition implies 
a passive role of the patient as the subject who does 
not participate actively in the treatment decision 
making process, since he is only given information 
and instructions regarding the use itself (11). The 
patient is expected to comply with received instruc-
tions and to be subordinated to the authority of a 
healthcare professional (2). Furthermore, in such a 
relation the patient is not encouraged to ask ques-
tions, clarify doubts concerning the therapy, or to 
inform the healthcare professional about the rea-
sons that may negatively influence the therapy 
management. In that case the patient is only an 
acceptant but not a contributor of useful infor-
mation, and there is only a one-way communica-
tion. Frequently, in such a model of interaction, the 
patient does not inform the physician or the phar-
macist about dietary supplements or traditional 
medicinal products which he potentially uses, nor 
about possible previous experiences with the pre-
scribed medicaments. All this can have serious con-
sequences to the safety and efficiency of the ther-
apy. In case the desired efficiency of the therapy is 
not achieved as the result of inadequate use, it is 
deemed that the patient has to bear the entire guilt, 
since he disobeyed received instructions.  
Although the term compliance has been in 
use for the longest period of time, nowadays it is 
considered that it is not entirely adequate and that 
changes in the relation between patients and 
healthcare professionals must be taken into consid-
eration.  Patients' status is no longer submissive 
and passive and their role in accomplishing thera-
peutic objectives does not only imply compliance 
with medical instructions but active cooperation 
and agreement with a doctor and a pharmacist. Due 
to these reasons the term adherence has become 
more desirable in practice since the 90’s of the 20th 
century (5,11). 
Adherence is defined as the extent to which 
a person’s behavior - taking medication, following a 
diet and/or executing lifestyle changes corresponds 
with agreed recommendations from a healthcare 
provider (12). It is also explained in literature as 
active, voluntary and collaborative involvement of 
the patient in a mutually acceptable course of be-
havior to produce a therapeutic result (13,14). 
Such a definition suggests that the patient has the 
right and possibility to decide about the therapy 
plan and to cooperate with the healthcare provider 
in defining therapy goals and regimens. The context 
of adherence does not only include the phase in 
which the patient takes prescribed medicine(s) on 
his own, but also the phase which precedes it, i.e. 
agreement and collaboration between the patient 
and healthcare providers. This concept indicates 
mutual responsibility for successful realization of 
adequate therapeutic regimen and defined goals. In 
such conditions there is more likelihood that pa-
tients would provide information, opinions and ex-
periences to a healthcare professional, which might 
influence the implementation and/or efficiency and 
safety of the therapy, as well as the probability of 
possible timely application of necessary modifica-
tions. Differences between compliance and adher-
ence are thus not only in the semantic sense but of 
essential nature. While in compliance the focus is 
on the healthcare provider who has a dominant sta-
tus in relation to the patient, the concept of adher-
ence is oriented to the patient and cooperation. In 
relation to this, the flow of information is one-way 
and the objective is to achieve obedience of the pa-
tient, while adherence implies a two-way infor-
mation transfer and engagement of both subjects. 
 A new approach in interpreting adherence 
started in the year 1997, when the environment in 
which the patient lives was taken into account, as 
well as the influence of that environment, the 
healthcare system and available practices on ad-
herence as a behavioral process (15, 16, 17). Ac-
cordingly, a low degree of adherence started to be 
treated as a complex problem that should be ap-
proached from different perspectives with carefully 
developed strategies and interventions directed to 
specific factors. Taxonomy proposed by Vrijens et 
al. in the year 2012 relies on three components of 
adherence: initiation, implementation, and discon-
tinuation (5). According to that division, non-adher-
ence may be in the form of late or missing initiation, 
suboptimal implementation, early discontinuation 
or combination of these cases. The term persis-
tence is defined as the time period between therapy 
initiation and the last dose which immediately pre-
cedes therapy discontinuation (5,10).  
World Health Organization gave its own defi-
nition of adherence in the year 2003 (12), while in 
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2009 the term medication adherence became a 
MeSH term (5). 
The concept of concordance was introduced 
by the joint working group assembled by the Royal 
Pharmaceutical Society of Great Britain in the year 
1995 (18,19,20). Introduction of this term empha-
sizes that, regardless of different perspectives of 
clinicians and patients, correct and adequate ad-
ministration of medicine(s) depends on their agree-
ment and cooperation, in which desires and convic-
tions of patients concerning the therapy must be 
taken into consideration. Concordance as a term in-
cludes a consultation process, in which a doctor and 
a patient agree on therapeutic decisions that incor-
porate their respective views and support to the pa-
tient in further implementation of the therapeutic 
plan. This term does not refer to mere actions of 
the patient in the process of medicine-taking, but 
rather a relation, interaction and partnership of the 
patient and healthcare providers. 
Compliance, adherence and persistence are 
parameters which can be quantified in contrast to 
terms like concordance and therapeutic alliance 
which do not possess measurable attributes, since 
they are based on the concept of cooperation, 
agreement and consultation between the patient 
and a healthcare provider considering therapeutic 
plan and shared responsibility for its success (3). 
Although adherence is discussed as categor-
ical, dichotomous variable in some studies, it is con-
sidered that such a presentation is not adequate for 
addressing the complexity of the adherence issue 
(21). It is therefore better to talk about a specific 
level of adherence than about arbitrary categories 
such as realized or unrealized, good or bad adher-
ence. Adherence as a continuous variable is most 
frequently expressed as an amount in percentage 
and/or with descriptive terms (a low/high, unsatis-
factory/satisfactory degree of adherence).  The 
same applies for the term compliance, while quan-
tification refers to determining the extent in which 
a patient acts in accordance with instructions re-
garding the dosages and dosage intervals of pre-
scribed medications during a defined period of time 
(10). It is important to note that concepts of adher-
ence and compliance must be analyzed in the sense 
of their modifications in the function of time, i.e. as 
measurements of dynamic character (22). When 
the taxonomy proposed by (5) Vrijens et al. is taken 
into consideration parameters of initiation and ther-
apy discontinuation are dichotomous, while the im-
plementation is a continuous variable (23). Persis-
tence is expressed as a time period, i.e. as a con-
tinuous variable and it is deemed recommendable 
to define in advance maximal allowed interval be-
tween doses in the form of the so-called permissible 
gap (5,10). That factor is determined further to 
pharmacological properties of the medicine and the 
condition of the patient thus representing the long-
est allowed period which may pass without admin-
istration of the prescribed dose of medicine or with-
out inducing suboptimal outcomes of the therapy 
(10,24,25). 
Although there are numerous methods for 
the assessment of the realized adherence level, 
evaluation of this parameter that significantly influ-
ences therapy outcomes is still qualified as prob-
lematic, nor has a gold standard been established 
in this field (12,26,27). The main problem in adher-
ence evaluation as a behavioral process is related 
to the fact that the measurement procedure, i.e. 
quantification itself influences the behavior of the 
patient. It is considered that if patients are con-
scious that their behavior regarding therapy imple-
mentation is monitored, they tend to modify a med-
icine-taking attitude and activities in order to 
demonstrate a (false) high level of adherence. Re-
searches have also shown that patients during ad-
herence monitoring tend to fulfill expectations of 
their doctors, avoid misunderstandings, disappoint-
ments and condemnations, and temporarily take 
the role of the so-called good patients who have 
achieved a satisfactory high level of adherence 
(28). All currently available methods for adherence 
assessment have certain deficiencies regarding ac-
curacy, ethicality, reliability, cost-effectiveness or 
simplicity of application and interpretation. When 
selecting the right method it is therefore necessary 
to make adequate compromise in relation to 
method limitations, available resources, the aim 
and goal of the research conducted. Methods for 
adherence evaluation are classified in two main 
groups: direct and indirect (27). The group of direct 
methods includes: directly observed therapy, 
measurement of the level of a drug or its metabolite 
in biological material of the patient and detection or 
determination of a biological marker added to the 
drug formulation. The other group of indirect meth-
ods includes: counting the remaining individual 
doses of the medicine (so-called pill counts), appli-
cation of devices for electronic monitoring of medic-
ament package frequency opening (so-called elec-
tronic monitoring devices), reviewing pharmacy 
prescription refills records and patients’ reports (di-
aries, questionnaires, interviews) analysis 
(27,28,29). It should be taken into consideration 
that none of the existing methods is universally ap-
plicable and that the most reliable information is 
obtained in conditions when it is possible to com-
bine more approaches parallel. Even though it is 
frequently very hard to accomplish this, it is the 
best way to significantly minimize limitations of 
methods when drawing final conclusions.  
 
Determinants of adherence level 
 
Numerous factors influence successful reali-
zation of adherence, considering the fact that ad-
herence is a multidimensional phenomenon. It is 
tremendously important to identify and analyze fac-
tors which individually and in mutual interaction 
create a framework that determines the adherence 
level so as to efficiently confront this growing prob-
lem. The World Health Organization has singled out 
five dimensions of adherence: patient-related fac-
tors, social- and economic-related factors, health 
system/health care team-related factors, condition-
related factors, and therapy-related factors (12). 
As to the factors which relate to the charac-
teristics of the patient, the correlation between age, 
gender, ethnical background, race, religious beliefs, 
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marriage status and the realization of desired level 
of cooperation with healthcare professionals has 
not been definitely determined (12,27). In con-
ducted studies there is no consistency in evaluating 
the significance of those demographic parameters. 
On the other hand, it is considered that psycholog-
ical and behavioral characteristics are important 
predictors of adherence (29, 30). Perception of own 
health condition, seriousness of illness and possible 
consequences, conviction of necessity of treatment 
all affect motivation and behavior of an individual 
regarding therapy administration (31). A frequent 
reason for insufficient dedication to adequate ther-
apy regimen implementation is attitudes that pa-
tients have in regard to medicines. Those include 
fear from experiencing harmful/unpleasant adverse 
effects of prescribed medicines, apprehension of 
unnatural origin of industrially produced medicines 
and concerns of possible development of addic-
tion/dependence. Furthermore, patients are influ-
enced by worry of potential difficult adaptation to 
lifestyle and habits’ alterations that are necessary 
in some conditions and therapies (12, 29). All those 
low levels of adherence risk factors can, however, 
be considered as preventable since they can be suc-
cessfully avoided or at least alleviated through 
communication with healthcare providers and pro-
cesses of consultation, counseling, support and mo-
tivation. Physical/somatic factors such as eyesight 
and hearing deteriorations, problems with swallow-
ing or decline of cognitive function can, on the other 
hand, significantly limit the ability of the patient to 
achieve a high level of adherence. Bearing this in 
mind a particular dedication is necessary and en-
gagement of healthcare providers in interaction and 
creation of tailor-made solutions for successful ful-
fillment of the therapeutic treatment plan. 
Health literacy is considered as the most im-
portant predictor of health condition and it is very 
important to reflect upon its influence on adher-
ence.  The World Health Organization (WHO) de-
fines health literacy as the cognitive and social skills 
which determine the motivation and ability of indi-
viduals to gain access to, understand and use infor-
mation in ways which promote and maintain good 
health (32). Health literacy, as a concept, includes 
political, economic and environmental factors which 
influence health, and because of this, it is here clas-
sified in the social- and economic-related factors 
category rather than in patient-related determi-
nants of adherence. Moreover, the responsibility for 
health literacy is not individual but shared among 
different sectors of the society and the goal is to 
ensure approach to and functional management of 
information which are significant for health, their 
critical analysis and exchange, as well as develop-
ment of the awareness about health determinants 
and stimulation of their improvement through indi-
vidual and collective activities.    
When it comes to pharmacotherapy it is es-
sential to ensure that patients can effectively man-
age available understandable information related to 
their health condition and therapy in order to 
achieve desired treatment outcomes. In that pro-
cess one of the main assumptions of safe and ef-
fective therapy is the ability of patients to name and 
recognize prescribed medicines, as well as to un-
derstand why they need to use them and how to do 
it adequately. Factors that might have negative ef-
fects on this are frequent changes of therapy and 
complex therapeutic plans, which include numerous 
medications with specific individual regimens (33). 
Researches indicate a worrying fact that up to 75% 
of patients cannot precisely name and explain their 
therapeutic regimen, while 46% patients wrongly 
interpret information about the dose and/or fre-
quency of administration of prescribed medica-
tion(s). Additionally, in a number of studies it has 
been determined that patients with a low level of 
health literacy have particular difficulties in under-
standing and application of instructions and advices 
related to medication usage (34). It is important for 
patients to have the knowledge of potential unde-
sirable side effects, contraindications, warnings and 
precautions so as to minimize risks regarding en-
dangerment of therapy safety. Patients should be 
empowered to recognize symptoms of possible ad-
verse effects, take adequate measures on time, as 
well as to understand the significance of reporting 
to healthcare professionals about all the problems 
associated with therapy management. Results of 
conducted researches, however, direct attention to 
unsatisfactory comprehension of this information, 
since it is estimated that up to 54% of patients have 
difficulties to understand ordinary warnings, while 
less than 10% of patients adheres to them rou-
tinely. Patients with low level of health literacy are 
exceptionally endangered, since studies have 
shown that patients in that category are 3.4 times 
less likely to interpret prescription medication 
warning labels correctly (35). 
Other social factors such as the family situa-
tion, residence conditions, employment and in-
comes may also influence adherence. Researches 
have suggested that low level of adherence risk is 
1.74 times higher in patients which do not come 
from stable, cohesive families, while conflictive 
family situation lowers the level of adherence 1.53 
times (36). Patients diagnosed with epilepsy, de-
pression, schizophrenia, HIV infection and other so-
cially stigmatized diseases often do not achieve a 
high level of adherence and consequently the full 
potential of the therapy (28). 
Particularly significant group of factors which 
determines adherence refers to healthcare provid-
ers and healthcare system. The relation between 
healthcare providers and patients will have a posi-
tive influence on adherence if it features mutual re-
spect, trust and shared dedication to creating and 
following an individualized treatment plan. Consid-
ering the fact that healthcare providers define diag-
noses, prescribe therapy, monitor clinical outcomes 
and provide feedback information to patients, vari-
ables which reflect interaction and communication 
manner between them represent key determinants 
of a realized adherence level and health outcomes 
(12). Communication which stimulates the patient 
to actively participate in the treatment process, in-
dicate potential problems and demand necessary 
explanations and advices, with adjusted terminol-
ogy and understandable expressions has a positive 
effect on adherence. There is a higher probability 
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that the patient will respect an agreement related 
to the therapy if he is satisfied with the work of 
healthcare providers and if the reasons for therapy 
administration, as well as the significance of con-
sistency in following the prescribed regimen has 
been clearly explained to him. Healthcare continuity 
and higher frequency of appointments are consid-
ered as predictors of better therapy management 
and higher level of adherence. Communication 
which emphasizes collaboration, expresses empa-
thy, support and motivation, allows open discussion 
of benefits, risks, and barriers to adherence en-
hances the quality of this relation and increases sat-
isfaction of the patient as the user of the healthcare 
system in regard to rendered services. Patients’ dis-
content concerning  interactions with members of 
the healthcare team, the type and scope of ob-
tained information, explanations and advice can 
represent an obstacle in achieving high level of ad-
herence (27,28,37). Neglecting patients’ opinions, 
demands and needs in decision making related to 
the therapy can result in negative attitude and frus-
tration among patients (12). Terminology used by 
the members of the healthcare team in their com-
munication with patients should be adapted to the 
knowledge, age, education, condition and needs of 
the patient.  
Characteristics of the healthcare system with 
reference to organization and resources availability, 
work efficiency and success in ensuring justice and 
financial protection from costs which may arise due 
to illness and disability all have significant influence 
on patient adherence (38). Relation between the 
healthcare system and adherence can be analyzed 
from a number of perspectives. Lack of financial 
and geographical accessibility of medical care, 
shortage of medications, long periods of waiting for 
scheduled diagnostic, therapy or rehabilitation pro-
cedures are considered as predictors of non-adher-
ence (29). A low level of adherence, on the other 
hand, influences the healthcare system through ir-
rational expenditure of already limited resources, 
additional unnecessary burden of the healthcare 
service and an increase of healthcare costs (38, 
39). Characteristics of the healthcare system can 
make a significant impact on the patients’ behavior, 
considering the fact that the healthcare system 
controls the process of resource allocation, terms of 
payment and medical care costs refunding, deter-
mines availability and possibility of patients’ medi-
cal history information exchange, as well as the 
continuity of medical care (12). For example, ex-
cessive work load of the healthcare provider with 
demanding schedule in relation to examinations, 
follow-ups and/or consultations with patients does 
not leave sufficient time to be dedicated to adher-
ence in communication. Additionally, lack of finan-
cial reimbursement for services of patient counsel-
ing has a negative influence on motivation of the 
healthcare team for development and implementa-
tion of adherence-focused interventions. Con-
versely, well developed healthcare information sys-
tem facilitates evaluation of adherence and repre-
sents a platform for a critical analysis and improve-
ment of work and organization efficacy. 
Condition-related factors influence adher-
ence as well. More problems with adherence might 
be expected in the category of chronic than in the 
category of acute illnesses, especially considering 
the dynamic aspect of the adherence phenomenon 
and modifications which arise in the function of time 
(7,12,40). Absence of illness symptoms can make 
adherence quite challenging, regarding the fact that 
they stimulate medication use by acting as a re-
minder or by reinforcing perceptions of need. A high 
level of obstructions of lifestyle patterns and usual 
daily activities coupled with the life quality decrease 
due to illness represent a good motivation factor 
and are associated with a higher adherence rate. A 
positive correlation between the severity of illness 
and success in achieving high adherence level has 
also been reported (2, 29). Conversely, a symptom 
withdrawal and clinical improvement before the ex-
piration of the planned therapy duration results in 
the perception that the illness is more benign than 
it actually is, leading to doubts about the necessity 
of a continuous treatment. Adherence-related prob-
lems might also be expected with patients who 
have psychiatric disorders and mental retardation 
(27,41). 
Numerous studies have suggested that 
polypharmacy, higher dosing frequency and a sig-
nificant impact of therapy on lifestyle and habits 
have a negative effect on adherence (5, 12, 27, 42, 
43). For example, a study conducted in the cate-
gory of patients with chronic cardiovascular dis-
eases estimated the adjusted weighted mean per-
centage adherence for medications taken two and 
three times per day were 6.9% and 13.7% lower, 
respectively, comparing with once daily dosing. It 
is important to emphasize that twice-daily dosing 
was associated with a 22.9% decrease in timing ad-
herence and this was 30.4% lower for medications 
taken three times per day when compared with 
medications taken once daily (44). In addition, 
higher incidence and severity of medication adverse 
effects have a negative impact on adherence and 
persistence, as well as inadequate dosage forms of 
the medicines which do not ensure comfortable 
therapy administration and/or are not tailored to 
the age, condition and needs of the patient 
(27,45,46). 
Combination and interaction of factors affect-
ing adherence are specific for each patient and it is 
remarkably important to comprehend them ade-
quately in order to create individualized, effective 
and sustainable solutions which promote adherence 




Understanding magnitude, a scope and con-
sequences of poor adherence, it is evidently neces-
sary to direct attention towards development and 
implementation of appropriate interventions. Nev-
ertheless, the complexity and mutual interaction of 
numerous factors which are considered as detri-
mental for patients’ medicine-taking behavior indi-
cate the complexity of that process. There is no uni-
versal strategy which would be efficient for all pa-
tients, in all conditions, regardless of the disease 
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type or the therapy prescribed. Therefore it is nec-
essary to create a general framework of interven-
tions which could be flexibly adapted further to 
unique individual needs and characteristics of the 
patient. Additionally, considering that adherence is 
a dynamic and multidimensional phenomenon the 
most successful measures are those which address 
the issue of adherence from different angles and 
which are revised according to modifications that 
arise in the function of time. 
Healthcare providers have a professional and 
ethical obligation to perform expert evaluation of 
the overall patients’ therapy, give information and 
advice, identify potentially existing factors which 
predispose a low adherence level, apply individually 
tailored strategies for adherence enhancement and 
continually monitor patient cooperation and ther-
apy outcomes. In order to empower them to suc-
cessfully fulfill all those responsibilities it is neces-
sary to insist on the development of adherence-re-
lated competences within the educational and pro-
grams of continual professional training, as well as 
to evolve consciousness about the significance of 
that aspect of the therapy management. In addi-
tion, it is essential to create a set of system-level 
measures so that members of a healthcare team 
can entirely comprehend the significance of coop-
eration and shared responsibility, as well as the po-
tential of a high quality collaborative practice. 
Since the low level of adherence is one of the 
main preventable causes of unsatisfactory therapy 
outcomes and excessive costs of medical care, it is 
evidently necessary to ensure a high quality base in 
the form of knowledge, skills and motivation at the 
level of the healthcare system for adherence eval-
uation and improvement, as well as a multidiscipli-
nary approach based on coordinated activities of 
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Adherenca je izuzetno važna za efikasnost i bezbednost farmakoterapije i značajno utiče 
na njene kliničke, ekonomske i humanističke ishode, što se može pratiti kako na individual-
nom nivou bolesnika, tako i na celokupnom zdravstvenom sistemu. Neadekvatan stepen 
adherence odavno je prisutan i široko rasprostranjen problem koji može imati velike i 
dugoročne posledice. Zato pitanje adherence predstavlja veliki izazov za zdravstvene profe-
sionalce u kliničkoj praksi. 
Koncept adherence je utemeljen na saradnji bolesnika i članova zdravstvenog tima u 
procesu upravljanja terapijom. U potpunosti je orjentisan ka bolesniku i podrazumeva dvos-
merni transfer informacija, dogovor i podeljenu odgovornost za uspešnost u realizaciji ad-
ekvatnog terapijskog režima i definisanih ciljeva.  
Iako postoji veliki broj metoda za procenu ostvarenog stepena adherence, još uvek se 
evaluacija ovog parametra smatra problematičnom. Kompleksnost adherence ogleda se u 
njenoj multidimenzionalnosti, budući da je identifikovan i proučen veliki broj faktora koji 
pojedinačno i u međusobnoj interakciji utiču na ponašanje bolesnika u vezi sa terapijom i 
tako kreiraju okvir koji determiniše ostvareni stepen adherence. 
Budući da je nizak stepen adherence jedan od glavnih preventabilnih uzroka nezado-
voljavajućih terapijskih ishoda i prekomernih troškova zdravstvene zaštite, evidentna je po-
treba da se obezbedi kvalitetna baza u formi znanja, veština i motivacije na nivou 
zdravstvenog sistema za evaluaciju i unapređenje adherence, kao i multidisciplinaran 
pristup, koji je zasnovan na koordinisanim aktivnostima  kreatora zdravstvene politike, 
istraživača i zdravstvenih profesionalaca. Acta Medica Medianae 2016;55(1):51-58. 
 
Ključne reči: adherenca, komplijansa, terminologija, determinante, zdravstveno 
ponašanje 
